Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study-Reference-Cited by-同舟云学术

Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study

Published:2024-05 Issue:5 Volume:11 Page:e358-e367
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Grover Natalie S,Hucks George,Riches Marcie L,Ivanova Anastasia,Moore Dominic T,Shea Thomas C,Seegars Mary Beth,Armistead Paul M,Kasow Kimberly A,Beaven Anne W,Dittus Christopher,Coghill James M,Jamieson Katarzyna J,Vincent Benjamin G,Wood William A,Cheng Catherine,Morrison Julia Kaitlin,West John,Cavallo Tammy,Dotti Gianpietro,Serody Jonathan S,Savoldo Barbara

Funder

NHLBI

NCI

Lymphoma Research Foundation of America

Publisher

Elsevier BV

Reference30 articles.

1. Classical Hodgkin lymphoma;Brice;Lancet,2021

2. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial;Schmitz;Lancet,2002

3. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma;Majhail;Biol Blood Marrow Transplant,2006

4. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial;Moskowitz;Lancet,2015

5. Overall survival with brentuximab vedotin in stage III or IV Hodgkin's lymphoma;Ansell;N Engl J Med,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in Adults;2024-07-11

2. The BTLA–HVEM axis restricts CAR T cell efficacy in cancer;Nature Immunology;2024-06

3. The value of anti-CD30 CAR T cells in Hodgkin lymphoma;The Lancet Haematology;2024-05